Amedica (AMDA) Reports Q3 Loss of $0.30

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. TMUS
9. VZ
10. LMT

Go back to Amedica (AMDA) Reports Q3 Loss of $0.30

Amedica Corporation Reports Third Quarter 2016 Financial Results

November 10, 2016 5:31 PM EST

SALT LAKE CITY, UT -- (Marketwired) -- 11/10/16 -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced financial results for the third quarter ended September 30, 2016.

Recent Company Highlights

Decreased year-to-date operational cash burn by 25% Received FDA clearance for Valeo II Lateral Lumbar interbody fusion device Submitted 510(k) to FDA for new Taurus metals system with first implantation expected by end of the year The first stage of testing of silicon nitride by the... More